A Secondary Analysis of a Preliminary Contingency Management Intervention for Presurgical Cancer Patients: Evaluating Individual Participant Data

被引:0
|
作者
Sanford, Brandon T. [1 ]
Toll, Benjamin A. [1 ,2 ,3 ,4 ]
Fucito, Lisa M. [4 ]
Baker, Nathaniel L. [1 ]
Krishnan-Sarin, Suchitra [4 ]
Carpenter, Matthew J. [1 ,2 ,3 ]
Bernstein, Steven L. [5 ]
Rojewski, Alana M. [1 ,3 ,6 ]
机构
[1] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA
[2] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA
[3] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC USA
[4] Yale Univ, Yale Sch Med, New Haven, CT USA
[5] Dartmouth Hitchcock Med Ctr, Geisel Sch Med, Hanover, NH USA
[6] 35 Cannon St,302K,MSC 835, Charleston, SC 29425 USA
基金
美国国家卫生研究院;
关键词
PREOPERATIVE SMOKING-CESSATION; POSTOPERATIVE COMPLICATIONS; SUBSTANCE USE; ABSTINENCE; DURATION; SURGERY;
D O I
10.1093/ntr/ntad071
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction Contingency management (CM) interventions deliver monetary reinforcers contingent upon biochemically verified abstinence from smoking. CM has been found to be effective, however, individual participant, analyses are warranted to further elucidate how individual-level behavior patterns vary during the intervention period, both within and across treatment groups. Aims and Methods This is a secondary analysis of a randomized controlled pilot trial of presurgical cancer patients who smoke (RCT N = 40). All participants were current everyday smokers and were enrolled in cessation counseling, offered nicotine replacement therapy, and submitted breath CO testing 3 times per week for 2-5 weeks. Participants randomized to CM received monetary reinforcers for breath CO <= 6 ppm on an escalating schedule of reinforcement with a reset for positive samples. Sufficient breath CO data exist for 28 participants (CM = 14; monitoring only [MO] = 14). Effect size was calculated for differences in negative CO tests. Time to first negative test was tested using survival analysis. Fisher's exact test was used to assess relapse. Results The CM group achieved abstinence more quickly (p < .05), had a lower percentage of positive tests (h = 0.80), and experienced fewer lapses following abstinence (p = .00). While 11 of 14 participants in the CM group achieved and sustained abstinence by their third breath test, this was only true for 2 of the 14 MO participants. Conclusions Those in CM achieved abstinence quicker and with fewer lapses than those engaged in MO speaking to the efficacy of the schedule of financial reinforcement. This is particularly important within presurgical populations given the potential benefits to postoperative cardiovascular and wound infection risk. Implications While the efficacy of CM as an intervention is well established, this secondary analysis provides insight into the individual behavior patterns underlying successful abstinence. Those assigned to CM were not only more likely to achieve abstinence, but did so more quickly and with fewer instances of relapse. This is of particular importance to those scheduled for surgery where achieving abstinence as early as possible impacts on the risk of postoperative complications. CM interventions may be particularly well suited for critical windows in which timely and sustained abstinence is advantageous.
引用
收藏
页码:1614 / 1618
页数:5
相关论文
共 50 条
  • [1] A Preoperative Contingency Management Intervention for Smoking Abstinence in Cancer Patients: A Preliminary Randomized Controlled Trial
    Rojewski, Alana M.
    Fucito, Lisa M.
    Baker, Nathaniel L.
    Krishnan-Sarin, Suchitra
    Carpenter, Matthew J.
    Bernstein, Steven L.
    Toll, Benjamin A.
    NICOTINE & TOBACCO RESEARCH, 2021, 23 (06) : 1064 - 1067
  • [2] Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis
    Schunemann, Holger J.
    Ventresca, Matthew
    Crowther, Mark
    Briel, Matthias
    Zhou, Qi
    Noble, Simon
    Macbeth, Fergus
    Griffiths, Gareth
    Garcia, David
    Lyman, Gary H.
    Di Nisio, Marcello
    Lorio, Alfonso
    Mbuagbaw, Lawrence
    Neumann, Ignacio
    van Es, Nick
    Brouwers, Melissa
    Guyatt, Gordon
    Streiff, MichaelB
    Marcucci, Mauro
    Baldeh, Tejan
    Florez, Ivan D.
    Alma, Oztem Gurunlu
    Solh, Ziad
    Bossuyt, Patrick M.
    Kahale, Lara A.
    Ageno, Walter
    Bozas, George
    Buller, Harry R.
    Lebeau, Bernard
    Lecumberri, Ramon
    Loprinzi, Charles
    McBane, Robert
    Sideras, Kostandinos
    Maraveyas, Anthony
    Pelzer, Uwe
    Perry, James
    Klerk, Clara
    Agnelli, Giancarlo
    Akl, Elie A.
    LANCET HAEMATOLOGY, 2020, 7 (10): : E746 - E755
  • [3] Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis
    van Tuijl, Lonneke A.
    Basten, Maartje
    Pan, Kuan-Yu
    Vermeulen, Roel
    Portengen, Luetzen
    de Graeff, Alexander
    Dekker, Joost
    Geerlings, Mirjam I.
    Hoogendoorn, Adriaan
    Lamers, Femke
    Voogd, Adri C.
    Abell, Jessica
    Awadalla, Philip
    Beekman, Aartjan T. F.
    Bjerkeset, Ottar
    Boyd, Andy
    Cui, Yunsong
    Frank, Philipp
    Galenkamp, Henrike
    Garssen, Bert
    Hellingman, Sean
    Huisman, Martijn
    Huss, Anke
    de Jong, Trynke R.
    Keats, Melanie R.
    Kok, Almar A. L.
    Krokstad, Steinar
    van Leeuwen, Flora E.
    Luik, Annemarie I.
    Noisel, Nolwenn
    Onland-Moret, N. Charlotte
    Payette, Yves
    Penninx, Brenda W. J. H.
    Rissanen, Ina
    Roest, Annelieke M.
    Ruiter, Rikje
    Schoevers, Robert A.
    Soave, David
    Spaan, Mandy
    Steptoe, Andrew
    Stronks, Karien
    Sund, Erik R.
    Sweeney, Ellen
    Twait, Emma L.
    Teyhan, Alison
    Verschuren, W. M. Monique
    van der Willik, Kimberly D.
    Rosmalen, Judith G. M.
    Ranchor, Adelita V.
    CANCER, 2023, 129 (20) : 3287 - 3299
  • [4] Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
    Copland, Emma
    Canoy, Dexter
    Nazarzadeh, Milad
    Bidel, Zeinab
    Ramakrishnan, Rema
    Woodward, Mark
    Chalmers, John
    Teo, Koon K.
    Pepine, Carl J.
    Davis, Barry R.
    Kjeldsen, Sverre
    Sundstrom, Johan
    Rahimi, Kazem
    LANCET ONCOLOGY, 2021, 22 (04): : 558 - 570
  • [5] The methodological quality of individual participant data meta-analysis on intervention effects: systematic review
    Wang, Huan
    Chen, Yancong
    Lin, Yali
    Abesig, Julius
    Wu, Irene X. Y.
    Tam, Wilson
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [6] Effects of the informed health choices secondary school intervention after 1 year: a prospective meta-analysis using individual participant data
    Faith Chesire
    Michael Mugisha
    Ronald Ssenyonga
    Christopher J. Rose
    Allen Nsangi
    Margaret Kaseje
    Nelson K. Sewankambo
    Matt Oxman
    Sarah E. Rosenbaum
    Jenny Moberg
    Astrid Dahlgren
    Simon Lewin
    Mahima Venkateswaran
    Eleni Papadopoulou
    Andrew D. Oxman
    Trials, 25 (1)
  • [7] Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis
    Beardmore-Gray, Alice
    Seed, Paul T.
    Fleminger, Jessica
    Zwertbroek, Eva
    Bernardes, Thomas
    Mol, Ben W.
    Battersby, Cheryl
    Koopmans, Corine
    Broekhuijsen, Kim
    Boers, Kim
    Owens, Michelle Y.
    Thornton, Jim
    Green, Marcus
    Shennan, Andrew H.
    Groen, Henk
    Chappell, Lucy C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (02) : 218 - +
  • [8] Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol
    Schunemann, Holger J.
    Ventresca, Matthew
    Crowther, Mark
    Briel, Matthias
    Zhou, Qi
    Garcia, David
    Lyman, Gary
    Noble, Simon
    Macbeth, Fergus
    Griffiths, Gareth
    DiNisio, Marcello
    Iorio, Alfonso
    Beyene, Joseph
    Mbuagbaw, Lawrance
    Neumann, Ignacio
    Van Es, Nick
    Brouwers, Melissa
    Brozek, Jan
    Guyatt, Gordon
    Levine, Mark
    Moll, Stephan
    Santesso, Nancy
    Streiff, Michael
    Baldeh, Tejan
    Florez, Ivan
    Alma, Ozlem Gurunlu
    Solh, Ziad
    Ageno, Walter
    Marcucci, Maura
    Bozas, George
    Zulian, Gilbert
    Maraveyas, Anthony
    Lebeau, Bernard
    Buller, Harry
    Evans, Jessica
    McBane, Robert
    Bleker, Suzanne
    Pelzer, Uwe
    Akl, Elie A.
    BMJ OPEN, 2016, 6 (04):
  • [9] Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis
    Takada, Toshihiko
    van Doorn, Sander
    Parpia, Sameer
    de Wit, Kerstin
    Anderson, David R.
    Stevens, Scott M.
    Woller, Scott C.
    ten Cate-Hoek, Arina J.
    Elf, Johan L.
    Kraaijenhagen, Roderik A.
    Schutgens, Roger E. G.
    Wells, Phil S.
    Kearon, Clive
    Moons, Karel G. M.
    Geersing, Geert-Jan
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2245 - 2252
  • [10] What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis
    Luigjes-Huizer, Yvonne L.
    Tauber, Nina M.
    Humphris, Gerry
    Kasparian, Nadine A.
    Lam, Wendy W. T.
    Lebel, Sophie
    Simard, Sebastien
    Smith, Allan Ben
    Zachariae, Robert
    Afiyanti, Yati
    Bell, Katy J. L.
    Custers, Jose A. E.
    de Wit, Niek J.
    Fisher, Peter L.
    Galica, Jacqueline
    Garland, Sheila N.
    Helsper, Charles W.
    Jeppesen, Mette M.
    Liu, Jianlin
    Mititelu, Roxana
    Monninkhof, Evelyn M.
    Russell, Lahiru
    Savard, Josee
    Speckens, Anne E. M.
    van Helmondt, Sanne J.
    Vatandoust, Sina
    Zdenkowski, Nicholas
    van der Lee, Marije L.
    PSYCHO-ONCOLOGY, 2022, 31 (06) : 879 - 892